BioCatalyst

TTX-381, TTX-381 — catalyst calendar

1 verified catalyst event(s) referencing TTX-381, TTX-381, each linked to its official source. Verified as of 2026-10-15.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 2mo
ESTIMATED
 READOUT
A Registrational Study of TTX-381 to Treat Vision Loss in CLN2 Disease
Phase 1/2 · Neuronal Ceroid Lipofuscinosis Type 2
 Tern Therapeutics, LLC TTX-381, TTX-381 ClinicalTrials.gov ↗
✓ Source-checked 2026-10-15
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.